Intellia Therapeutics, Inc. (NTLA) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Intellia Therapeutics, Inc. (NTLA): 1Y return -48.7%, Sharpe ratio -0.23, volatility 89.8%, max drawdown -71.3%. A Stock in the Equity asset class. Compare NTLA with other assets and invest through your own broker with pfolio.
Intellia Therapeutics, Inc. (NTLA) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
NTLA Performance
- MTD
- Return: 4.3%, Sharpe: 2.20, Volatility: 70.4%, Max Drawdown: -8.2%
- YTD
- Return: 39.9%, Sharpe: 0.92, Volatility: 76.1%, Max Drawdown: -40.2%
- 1Y
- Return: -48.7%, Sharpe: -0.23, Volatility: 89.8%, Max Drawdown: -71.3%
- 5Y
- Return: -90.2%, Sharpe: -0.20, Volatility: 76.4%, Max Drawdown: -95.5%
- 10Y
- Return: 1.9%, Sharpe: 0.39, Volatility: 77.0%, Max Drawdown: -96.4%
Frequently Asked Questions
- What is Intellia Therapeutics, Inc. (NTLA)?
- Intellia Therapeutics, Inc. (NTLA) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does NTLA compare to other assets?
- You can compare NTLA with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in NTLA through pfolio?
- pfolio helps you build diversified portfolios that may include NTLA. You invest through your own broker — pfolio provides the analytics.